According to a new press release, “Clarivate Analytics Plc a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced that Cortellis Clinical Trials Intelligence™ has been enhanced with new site selection analytics. Cortellis Clinical Trials Intelligence is a powerful and user-friendly resource to plan clinical trials, helping to accelerate clinical trial development decisions, select trial sites, inform portfolio strategy and provide key competitive intelligence.”

The release continues, “The enhanced solution allows clinical development and operations professionals to make more confident decisions around trial design, site selection and validation with a single point of access to continuously updated and curated protocol, biomarker, patient segmentation, endpoint, and site data. Clinical operations professionals can better position trials for success leveraging intuitive analytics, simple search capabilities, targeted data filters and content indexing. In addition, Cortellis Clinical Trials Intelligence is designed to seamlessly integrate with the broader Cortellis suite of life science solutions to enable data-driven decisions across the entire development and commercialization lifecycle.”

Keith Collier, Vice President of Product Management at Clarivate, said: “There is significant risk and complexity in planning a successful clinical trial. Clinical operations teams are tasked with evaluating and selecting experienced and reliable sites to fully recruit patients and support overall trial success. They risk spending significant time and money working with sites that can’t deliver. The new sites content in Cortellis Clinical Trials Intelligence addresses those challenges, helps to reduce the risks and enables more confident clinical planning decisions – all within a single source of comprehensive clinical development and operations data.”

Read more at PR Newswire.

Image used under license from Shutterstock.com